Literature DB >> 9600575

Adenosine A1 receptors modulate anxiety in CD1 mice.

C Florio1, A Prezioso, A Papaioannou, R Vertua.   

Abstract

The effect of the selective adenosine A1 receptor agonist 2-chloro-N6-cyclopentyladenosine (CCPA) was investigated in CD1 mice by the elevated plus-maze and the light/dark test, two models for measuring anxiety in rodents. CCPA, administered i.p., had an anxiolytic effect at 0.3 nmol/kg in the elevated plus-maze and at 1 nmol/kg in the light/dark test. Brain levels of 22 nM were found after administration of 100 nmol/kg CCPA, as measured by ex vivo binding experiments. These values are consistent with the occupancy of adenosine A1 but not A2 receptors by CCPA, and suggest that the anxiolytic-like action of CCPA may be mediated by centrally located adenosine A1 receptors. Both CPT, a selective adenosine A1 receptor antagonist, and IBMX, a non-selective adenosine antagonist, had an anxiogenic effect in the two tests. It is thus possible that purinergic neurons may be involved in the tonic modulation of affective state in mice.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9600575     DOI: 10.1007/s002130050572

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  16 in total

1.  Modulation of the hypothalamo-pituitary-adrenocortical axis by caffeine.

Authors:  Michael D Patz; Heidi E W Day; Andrew Burow; Serge Campeau
Journal:  Psychoneuroendocrinology       Date:  2006-01-04       Impact factor: 4.905

Review 2.  The Impact of Caffeine on the Behavioral Effects of Ethanol Related to Abuse and Addiction: A Review of Animal Studies.

Authors:  Laura López-Cruz; John D Salamone; Mercè Correa
Journal:  J Caffeine Res       Date:  2013-03

3.  Acute restraint stress in zebrafish: behavioral parameters and purinergic signaling.

Authors:  Angelo L Piato; Denis B Rosemberg; Katiucia M Capiotti; Anna M Siebel; Ana P Herrmann; Gabriele Ghisleni; Monica R Vianna; Maurício R Bogo; Diogo R Lara; Carla D Bonan
Journal:  Neurochem Res       Date:  2011-05-21       Impact factor: 3.996

4.  Role of nitric oxide in the behavioral and neurochemical effects of IB-MECA in zebrafish.

Authors:  Caio Maximino; Julliany Gemaque; Rancés Benzecry; Monica Gomes Lima; Evander de Jesus Oliveira Batista; Domingos Wanderley Picanço-Diniz; Karen Renata Matos Oliveira; Anderson Manoel Herculano
Journal:  Psychopharmacology (Berl)       Date:  2014-11-13       Impact factor: 4.530

5.  Restoring auditory cortex plasticity in adult mice by restricting thalamic adenosine signaling.

Authors:  Jay A Blundon; Noah C Roy; Brett J W Teubner; Jing Yu; Tae-Yeon Eom; K Jake Sample; Amar Pani; Richard J Smeyne; Seung Baek Han; Ryan A Kerekes; Derek C Rose; Troy A Hackett; Pradeep K Vuppala; Burgess B Freeman; Stanislav S Zakharenko
Journal:  Science       Date:  2017-06-30       Impact factor: 47.728

Review 6.  Purinergic system in psychiatric diseases.

Authors:  A Cheffer; A R G Castillo; J Corrêa-Velloso; M C B Gonçalves; Y Naaldijk; I C Nascimento; G Burnstock; H Ulrich
Journal:  Mol Psychiatry       Date:  2017-09-26       Impact factor: 15.992

7.  Chronic treatment with DCPCX, an adenosine A(1) antagonist, worsens long-term memory.

Authors:  Craig Vollert; Gloria S Forkuo; Richard A Bond; Jason L Eriksen
Journal:  Neurosci Lett       Date:  2013-06-06       Impact factor: 3.046

8.  Activation of adenosine(1) (A(1)) receptors suppresses head shakes induced by a serotonergic hallucinogen in rats.

Authors:  Gerard J Marek
Journal:  Neuropharmacology       Date:  2009-03-24       Impact factor: 5.250

9.  Tianeptine: an antidepressant with memory-protective properties.

Authors:  Phillip R Zoladz; Collin R Park; Carmen Muñoz; Monika Fleshner; David M Diamond
Journal:  Curr Neuropharmacol       Date:  2008-12       Impact factor: 7.363

10.  Pharmacological alterations of anxious behaviour in mice depending on both strain and the behavioural situation.

Authors:  Yan Clément; Anne-Marie Le Guisquet; Patrice Venault; Georges Chapouthier; Catherine Belzung
Journal:  PLoS One       Date:  2009-11-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.